Verified ProfileEN

Kaishilun (Tianjin) Biotechnology Co., Ltd.

Order verification — $199

Scientific Research and Technical Services · Technology Promotion Services

Verification dossier

Kaishilun (Tianjin) Biotechnology Co., Ltd. is a Chinese company based in Tianjin. The company operates in the technology promotion services sector, within the broader scientific research and technical services industry. Established 2018, the company has been operating for 8 years.

Sinolinks tracks Kaishilun (Tianjin) Biotechnology Co., Ltd. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Technology services, development, consulting, exchange, transfer, promotion; Class II medical device sales; Class I medical device production and sales; online sales (excluding licensed goods); cosmetics retail and wholesale; specialty chemical sales (excluding hazardous chemicals); IT consulting services; information consulting services (excluding licensed items); engineering and technical research and experimental development (excluding stem cell, gene diagnosis/treatment technology development and application, and rare/unique Chinese varieties); biochemical product R&D. (Operates autonomously based on business license for items not requiring approval).

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review